Through this collaboration, Boehringer Ingelheim and Google plan to focus on the implementation of quantum computing in pharmaceutical research and development, including molecular dynamics simulations.

(Subscribe to our Today’s Cache newsletter for a quick rundown of the 5 best tech stories. Click here to subscribe for free.)

Google’s Quantum AI division has partnered with German pharmaceutical company Boehringer Ingelheim to develop new drugs using quantum computing.

Through this collaboration, Boehringer Ingelheim and Google plan to focus on the implementation of quantum computing in pharmaceutical research and development, including molecular dynamics simulations.

While Boehringer Ingelheim will focus on computer-aided drug design and in silico modeling, Google will provide quantum computers and algorithms.

“With Google, our goal is to apply the use of quantum computing to biopharmaceutical R&D and thus continue to make a decisive contribution to medical progress for patients around the world”, Michel Pairet, member of the board of directors head of the company’s innovation unit at Boehringer Ingelheim, said in a statement.

Read also: Google launches simulator to help researchers develop quantum algorithms

The idea is to use quantum computing to solve complex challenges during the early stages of pharmaceutical R&D, which today’s computers are unable to solve.

Quantum computing has the potential to accurately simulate and compare molecules much larger than is currently possible, according to Boehringer Ingelheim. This will create new opportunities for pharmaceutical innovation and therapies for a range of diseases.

“Extremely precise modeling of molecular systems is widely regarded as one of the most natural and potentially transformative applications of quantum computing,” said Ryan Babbush, head of quantum algorithms at Google.

Read also: IBM plans to build an 1121 qubit system. What does this technology mean?

Boehringer Ingelheim said it is the first pharmaceutical company in the world to partner with Google in the field of quantum computing. The partnership is designed for three years and is co-led by the new Quantum Lab from Boehringer Ingelheim.

You’ve reached your free item limit this month.

Membership benefits include

Today’s paper

Find a mobile version of daily newspaper articles in an easy-to-read list.

Unlimited access

Enjoy reading as many articles as you want without any limitations.

Personalized recommendations

A short list of items that match your interests and tastes.

Faster pages

Switch easily from article to article, as our pages load instantly.

Dashboard

A one-stop shop to see the latest updates and manage your preferences.

Report

We keep you informed of the most recent and important developments, three times a day.

Support quality journalism.

* Our digital subscription plans currently do not include e-paper, crossword puzzles, and printing.